1. Alternative procedures for blood and blood components during the COVID-19 public health emergency Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, April 2020 Subject(s): Blood DonorsBlood TransfusionPlasmaCOVID-19United StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Investigational COVID-19 convalescent plasma Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, February 11, 2021 Subject(s): Antibodies, ViralBlood DonorsCOVID-19 -- therapyPlasmaUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Considerations for the development of dried plasma products intended for transfusion Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2019 Subject(s): Blood Transfusion -- standardsDevice ApprovalDrug ApprovalDrug Development -- standardsPlasmaPlasma -- microbiologyProduct PackagingQuality ControlHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
